{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:26:49Z","timestamp":1791563209051,"version":"4.3.4"},"reference-count":71,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HPF\/2010\/17"],"award-info":[{"award-number":["HPF\/2010\/17"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["TRA\/2007\/5"],"award-info":[{"award-number":["TRA\/2007\/5"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainstimjrnl.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Stimulation"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.brs.2018.05.011","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T12:46:02Z","timestamp":1526647562000},"page":"1123-1131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9264-8757","authenticated-orcid":false,"given":"Karen M.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4574-2799","authenticated-orcid":false,"given":"Declan M.","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brs.2018.05.011_bib1","series-title":"Depression and other common mental disorders: global Health estimates","author":"World Health Organisation","year":"2017"},{"key":"10.1016\/j.brs.2018.05.011_bib2","first-page":"317","article-title":"Depression is the leading cause of disability around the world","volume":"1517","author":"Friedrich","year":"2017","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.brs.2018.05.011_bib3","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A\u00a0neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol Psychiatr"},{"issue":"3","key":"10.1016\/j.brs.2018.05.011_bib4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10571-017-0510-4","article-title":"BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity","volume":"38","author":"Kowianski","year":"2018","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.brs.2018.05.011_bib5","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1523\/JNEUROSCI.15-03-01768.1995","article-title":"Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus","volume":"15","author":"Smith","year":"1995","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.brs.2018.05.011_bib6","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","author":"Nibuya","year":"1995","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.brs.2018.05.011_bib7","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.pnpbp.2009.04.002","article-title":"Reduced platelet BDNF level in patients with major depression","volume":"33","author":"Lee","year":"2009","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.brs.2018.05.011_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jad.2006.11.005","article-title":"Decreased plasma BDNF level in depressive patients","volume":"101","author":"Lee","year":"2007","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.brs.2018.05.011_bib9","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.pnpbp.2006.03.025","article-title":"Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women","volume":"30","author":"Aydemir","year":"2006","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.brs.2018.05.011_bib10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3109\/15622971003611319","article-title":"Serum and plasma BDNF levels in major depression: a replication study and meta-analyses","volume":"11","author":"Bocchio-Chiavetto","year":"2010","journal-title":"World J Biol Psychiatr"},{"key":"10.1016\/j.brs.2018.05.011_bib11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/geronb\/gbu096","article-title":"Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression","volume":"69","author":"Diniz","year":"2014","journal-title":"J\u00a0Gerontol B Psychol Sci Soc Sci"},{"key":"10.1016\/j.brs.2018.05.011_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1503\/jpn.100048","article-title":"Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders","volume":"36","author":"Thompson Ray","year":"2011","journal-title":"J\u00a0Psychiatry Neurosci"},{"key":"10.1016\/j.brs.2018.05.011_bib13","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1176\/appi.ajp.2012.12020248","article-title":"Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder","volume":"169","author":"Tripp","year":"2012","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.brs.2018.05.011_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-3223(01)01083-6","article-title":"Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication","volume":"50","author":"Chen","year":"2001","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.brs.2018.05.011_bib15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000444220","article-title":"Effect of mirtazapine treatment on serum levels of brain-derived neurotrophic factor and tumor necrosis factor-alpha in patients of major depressive disorder with severe depression","volume":"97","author":"Gupta","year":"2016","journal-title":"Pharmacology"},{"key":"10.1016\/j.brs.2018.05.011_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141564","article-title":"Brain-derived neurotrophic factor and antidepressive effect of electroconvulsive therapy: systematic review and meta-analyses of the preclinical and clinical literature","volume":"10","author":"Polyakova","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.brs.2018.05.011_bib17","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.pnpbp.2011.06.013","article-title":"Serum BDNF levels before treatment predict SSRI response in depression","volume":"35","author":"Wolkowitz","year":"2011","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.brs.2018.05.011_bib18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1461145708009309","article-title":"A\u00a0systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression","volume":"11","author":"Brunoni","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.brs.2018.05.011_bib19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/mp.2013.105","article-title":"Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)","volume":"19","author":"Molendijk","year":"2014","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.brs.2018.05.011_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.brs.2018.05.011_bib21","first-page":"12","article-title":"Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis","volume":"7","author":"Hosang","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.brs.2018.05.011_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.euroneuro.2009.12.005","article-title":"Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder","volume":"20","author":"Zou","year":"2010","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.brs.2018.05.011_bib23","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/da.22060","article-title":"Efficacy and acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: a systematic review and meta-analysis of randomized trials","volume":"30","author":"Berlim","year":"2013","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.brs.2018.05.011_bib24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.brs.2018.05.011_bib25","first-page":"181","article-title":"Molecular and cellular actions of chronic electroconvulsive seizures","volume":"14","author":"Duman","year":"1998","journal-title":"J\u00a0ECT"},{"key":"10.1016\/j.brs.2018.05.011_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neures.2009.01.014","article-title":"Neurophysiological mechanisms of electroconvulsive therapy for depression","volume":"64","author":"Kato","year":"2009","journal-title":"Neurosci Res"},{"key":"10.1016\/j.brs.2018.05.011_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.100","article-title":"Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all?","volume":"5","author":"van Buel","year":"2015","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.brs.2018.05.011_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neulet.2013.05.035","article-title":"Electroconvulsive stimulation alters levels of BDNF-associated microRNAs","volume":"549","author":"Ryan","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.brs.2018.05.011_bib29","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1017\/S1461145714000200","article-title":"Effects of brief pulse and ultrabrief pulse electroconvulsive stimulation on rodent brain and behaviour in the corticosterone model of depression","volume":"17","author":"O'Donovan","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.brs.2018.05.011_bib30","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1523\/JNEUROSCI.5377-03.2004","article-title":"Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways","volume":"24","author":"Altar","year":"2004","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.brs.2018.05.011_bib31","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1523\/JNEUROSCI.0237-07.2007","article-title":"Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates","volume":"27","author":"Perera","year":"2007","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.brs.2018.05.011_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpsychires.2016.08.004","article-title":"Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: a meta-analysis study","volume":"83","author":"Rocha","year":"2016","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.brs.2018.05.011_bib33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/15622975.2014.892633","article-title":"BDNF blood levels after electroconvulsive therapy in patients with mood disorders: a systematic review and meta-analysis","volume":"15","author":"Brunoni","year":"2014","journal-title":"World J Biol Psychiatr"},{"key":"10.1016\/j.brs.2018.05.011_bib34","article-title":"Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression","volume":"12","author":"Zhou","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.brs.2018.05.011_bib35","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.brs.2018.05.011_bib36","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1176\/appi.ajp.2015.15030372","article-title":"Bitemporal versus high-dose unilateral twice-weekly electroconvulsive therapy for depression (EFFECT-Dep): a pragmatic, randomized, non-inferiority trial","volume":"173","author":"Semkovska","year":"2016","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.brs.2018.05.011_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.51","article-title":"Electroconvulsive therapy modulates plasma pigment epithelium-derived factor in depression: a proteomics study","volume":"7","author":"Ryan","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.brs.2018.05.011_bib38","series-title":"Structured clinical Interview for DSM-IV Axis I disorders, clinician version (SCID-CV)","author":"First","year":"1996"},{"key":"10.1016\/j.brs.2018.05.011_bib39","series-title":"Hamilton rating scale for depression, ECDEU version used in the treatment of depression collaborative Research program. Handbook of depression-treatment, assessment and Research","author":"Beckham","year":"1985"},{"key":"10.1016\/j.brs.2018.05.011_bib40","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.metabol.2006.02.012","article-title":"Serum brain-derived neurotrophic factor level is increased and associated with obesity in newly diagnosed female patients with type 2 diabetes mellitus","volume":"55","author":"Suwa","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.brs.2018.05.011_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2007.05.064","article-title":"Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation","volume":"423","author":"Kim","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.brs.2018.05.011_bib42","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/archpsyc.63.7.824","article-title":"Association between obesity and psychiatric disorders in the US adult population","volume":"63","author":"Simon","year":"2006","journal-title":"Arch Gen Psychiatr"},{"key":"10.1016\/j.brs.2018.05.011_bib43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archpsyc.1993.01820130038007","article-title":"Smoking and major depression. A causal analysis","volume":"50","author":"Kendler","year":"1993","journal-title":"Arch Gen Psychiatr"},{"key":"10.1016\/j.brs.2018.05.011_bib44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ajmg.b.20118","article-title":"Ethnic difference of the BDNF 196G\/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits","volume":"126B","author":"Shimizu","year":"2004","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.brs.2018.05.011_bib45","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/mp.2008.109","article-title":"Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity","volume":"15","author":"Verhagen","year":"2010","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.brs.2018.05.011_bib46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/mp.2008.80","article-title":"The Met\u00a0allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations","volume":"14","author":"Lang","year":"2009","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.brs.2018.05.011_bib47","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1017\/S0033291709005509","article-title":"The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression","volume":"39","author":"Montag","year":"2009","journal-title":"Psychol Med"},{"key":"10.1016\/j.brs.2018.05.011_bib48","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1601-183X.2010.00579.x","article-title":"Plasma BDNF concentration, Val66Met genetic variant and depression-related personality traits","volume":"9","author":"Terracciano","year":"2010","journal-title":"Gene Brain Behav"},{"key":"10.1016\/j.brs.2018.05.011_bib49","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.biopsych.2005.01.008","article-title":"Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity","volume":"57","author":"Karege","year":"2005","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.brs.2018.05.011_bib50","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pnpbp.2006.06.024","article-title":"Low plasma BDNF is associated with suicidal behavior in major depression","volume":"31","author":"Kim","year":"2007","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.brs.2018.05.011_bib51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jad.2007.05.005","article-title":"Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments","volume":"105","author":"Piccinni","year":"2008","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.brs.2018.05.011_bib52","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-3223(03)00181-1","article-title":"Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants","volume":"54","author":"Shimizu","year":"2003","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.brs.2018.05.011_bib53","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/mp.2010.98","article-title":"Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment","volume":"16","author":"Molendijk","year":"2011","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.brs.2018.05.011_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2004.03.002","article-title":"The impact of age, weight and gender on BDNF levels in human platelets and plasma","volume":"26","author":"Lommatzsch","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.brs.2018.05.011_bib55","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000352013","article-title":"Electroconvulsive therapy improves clinical manifestation with plasma BDNF levels unchanged in treatment-resistant depression patients","volume":"68","author":"Lin","year":"2013","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.brs.2018.05.011_bib56","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4088\/JCP.v68n0404","article-title":"Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression","volume":"68","author":"Marano","year":"2007","journal-title":"J\u00a0Clin Psychiatr"},{"key":"10.1016\/j.brs.2018.05.011_bib57","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.euroneuro.2009.01.002","article-title":"Plasma brain-derived neurotrophic factor in treatment-resistant depressed patients receiving electroconvulsive therapy","volume":"19","author":"Piccinni","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.brs.2018.05.011_bib58","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jpsychires.2013.03.006","article-title":"Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only","volume":"47","author":"Haghighi","year":"2013","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.brs.2018.05.011_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2016.01.012","article-title":"Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder","volume":"76","author":"Salehi","year":"2016","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.brs.2018.05.011_bib60","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1677\/JOE-07-0376","article-title":"Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm","volume":"197","author":"Begliuomini","year":"2008","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.brs.2018.05.011_bib61","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ajmg.b.30686","article-title":"Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis","volume":"147B","author":"Chen","year":"2008","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.brs.2018.05.011_bib62","first-page":"129","article-title":"Effects of COMT, DRD2, BDNF, and APOE genotypic variation on treatment efficacy and cognitive side effects of electroconvulsive therapy","volume":"31","author":"Bousman","year":"2015","journal-title":"J\u00a0ECT"},{"key":"10.1016\/j.brs.2018.05.011_bib63","first-page":"243","article-title":"Differences in cognitive outcomes after ECT depending on BDNF and COMT polymorphisms","volume":"32","author":"Bennett","year":"2016","journal-title":"J\u00a0ECT"},{"key":"10.1016\/j.brs.2018.05.011_bib64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00406-006-0679-x","article-title":"Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder","volume":"257","author":"Huuhka","year":"2007","journal-title":"Eur Arch Psychiatr Clin Neurosci"},{"key":"10.1016\/j.brs.2018.05.011_bib65","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000478862","article-title":"Plasma BDNF level in major depression: biomarker of the Val66Met BDNF polymorphism and of the clinical course in Met Carrier patients","volume":"75","author":"Colle","year":"2017","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.brs.2018.05.011_bib66","first-page":"1","article-title":"Val66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression","author":"Caldieraro","year":"2017","journal-title":"World J Biol Psychiatr"},{"key":"10.1016\/j.brs.2018.05.011_bib67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/appy.12148","article-title":"Brain-derived neurotrophic factor Val66Met polymorphism association with antidepressant efficacy: a systematic review and meta-analysis","volume":"6","author":"Yan","year":"2014","journal-title":"Asia Pac Psychiatr"},{"key":"10.1016\/j.brs.2018.05.011_bib68","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0029-1224162","article-title":"Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats","volume":"42","author":"Sartorius","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.brs.2018.05.011_bib69","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0169-328X(95)00250-V","article-title":"Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF","volume":"36","author":"Poduslo","year":"1996","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.brs.2018.05.011_bib70","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1128\/CVI.00385-07","article-title":"Enzyme-linked immunosorbent assay for detection of Plasmodium falciparum histidine-rich protein 2 in blood, plasma, and serum","volume":"15","author":"Kifude","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.brs.2018.05.011_bib71","series-title":"USDHHS FDA Center for Drug Evaluation and Research. Guidance for industry: bioanalytical method validation","year":"2001"}],"container-title":["Brain Stimulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X1830158X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X1830158X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:11:09Z","timestamp":1761833469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1935861X1830158X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1935861X1830158X"],"URL":"https:\/\/doi.org\/10.1016\/j.brs.2018.05.011","relation":{},"ISSN":["1935-861X"],"issn-type":[{"value":"1935-861X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy","name":"articletitle","label":"Article Title"},{"value":"Brain Stimulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brs.2018.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}